Barbiturates slow down your central nervous system by amplifying the effects of your brain’s main calming chemical, a neurotransmitter called GABA. This produces a spectrum of effects depending on the dose: mild sedation at the low end, general anesthesia and complete unconsciousness at the high end. Once the most widely prescribed sedatives in the world, barbiturates have largely been replaced by safer alternatives, though a handful remain in clinical use for specific conditions.
How Barbiturates Affect Your Brain
Your brain has receptors designed to respond to GABA, a neurotransmitter that naturally dampens nerve activity. Barbiturates bind to these GABA receptors and change how their chloride channels behave. Normally, these channels flicker open briefly. Barbiturates shift the channels toward their longest open state (about 9 milliseconds instead of 1 or 3), which means more chloride ions flow into the nerve cell. That influx makes the cell less likely to fire, essentially quieting brain activity.
This is different from how benzodiazepines (like diazepam or lorazepam) work on the same receptor. Benzodiazepines increase how often the channel opens, but they can’t force the channel open on their own. Barbiturates can. At high enough doses, barbiturates activate the chloride channel directly, even without GABA present. They also block glutamate, the brain’s primary excitatory chemical, and reduce calcium flow through nerve cell membranes. The combination of boosting inhibition while simultaneously suppressing excitation is what makes barbiturates so potent, and so dangerous.
Effects on the Body
At low doses, barbiturates produce relaxation, drowsiness, and reduced anxiety, feelings similar to alcohol intoxication. As the dose increases, the effects deepen: slurred speech, loss of coordination, confusion, and eventually unconsciousness. These drugs don’t just affect the brain. They slow activity throughout the body.
The cardiovascular system is affected through dilation of blood vessels, which lowers blood pressure, along with a direct weakening effect on heart contractions. Gut motility slows down. Body temperature can drop because barbiturates suppress the temperature-regulating center in the brainstem. The most clinically significant effect, and the one responsible for most barbiturate deaths, is respiratory depression. Barbiturates suppress the brain’s breathing centers, reducing the drive to breathe. At toxic doses, breathing can stop entirely.
Why They’re Considered Dangerous
The core problem with barbiturates is their narrow therapeutic window, meaning the difference between a dose that produces the desired effect and a dose that causes life-threatening toxicity is small. Unlike benzodiazepines, which have a relatively wide margin of safety, barbiturates lack a reliable ceiling on how much they can suppress the central nervous system. Each incremental increase in dose pushes further toward respiratory failure.
Overdose symptoms follow a predictable escalation: confusion, then decreased consciousness, then coma with loss of brainstem reflexes. Blood pressure drops, heart rate becomes abnormal, breathing slows or stops, and body temperature falls. There is no specific antidote for barbiturate poisoning. This narrow safety margin is the main reason benzodiazepines replaced barbiturates for most uses starting in the 1970s and 1980s.
Current Medical Uses
Six barbiturates are still FDA-approved for clinical use in the United States. Their applications are narrow but important.
- Seizure disorders: Phenobarbital remains a go-to antiepileptic drug for newborns and children, and it’s the most cost-effective epilepsy treatment in lower-resource countries. In the U.S., it serves as a second-line option. Primidone is also prescribed for seizure disorders.
- Anesthesia and procedural sedation: Methohexital is used for short procedures like cardioversion and pediatric outpatient surgery, and it’s the preferred sedative for electroconvulsive therapy. Pentobarbital is given before anesthesia as a pre-surgical sedative.
- Severe brain swelling: When traumatic brain injury causes dangerously elevated pressure inside the skull that doesn’t respond to other treatments, high-dose barbiturate therapy can be used to induce a medical coma, reducing the brain’s metabolic demand and lowering pressure.
- Headache: Butalbital is combined with other pain relievers in prescription headache medications, one of the more common ways people encounter barbiturates today.
Drug Interactions and Enzyme Induction
Barbiturates cause a significant problem that extends beyond their direct effects: they ramp up the liver’s drug-metabolizing enzymes. Your liver uses a family of enzymes called cytochrome P450 to break down medications. Barbiturates, particularly phenobarbital, increase the activity of these enzymes, which means other medications you take get broken down faster and may not work as well.
This affects a wide range of drugs, including certain heart medications, blood thinners, hormonal contraceptives, and other sedatives. If you’re taking a barbiturate alongside another medication, the second drug may need a higher dose to remain effective, and stopping the barbiturate can suddenly cause the other drug’s levels to spike. This enzyme-induction effect can persist for weeks after the barbiturate is discontinued because the liver takes time to return to baseline activity.
Barbiturates are also strictly avoided in people with a condition called acute intermittent porphyria, a genetic disorder affecting how the body produces heme (a component of hemoglobin). Barbiturates can trigger severe, potentially fatal attacks in these patients.
Dependence and Withdrawal
Regular barbiturate use produces both psychological and physical dependence. The body adapts to the constant suppression of nerve activity by becoming more excitable at baseline, so when the drug is removed, the nervous system rebounds. Withdrawal symptoms typically begin two to four days after the last dose and can include anxiety, restlessness, insomnia, tremors, dizziness, seizures, and psychosis.
Barbiturate withdrawal is medically serious. Unlike opioid withdrawal, which is intensely uncomfortable but rarely fatal, untreated barbiturate withdrawal can progress to dangerously high body temperature, cardiovascular collapse, and death. This places barbiturate withdrawal in the same risk category as alcohol withdrawal, and it requires medical supervision and a gradual tapering protocol rather than abrupt discontinuation.
How Barbiturates Compare to Modern Sedatives
Benzodiazepines largely replaced barbiturates for anxiety, insomnia, and seizure management because they offer a wider safety margin. Both drug classes work on the same GABA receptor, but benzodiazepines require GABA to already be present to have their effect. They enhance what’s already happening rather than forcing the system open. This built-in limitation makes fatal overdose from benzodiazepines alone far less likely, though combining them with alcohol or opioids removes that safety advantage.
Barbiturates still hold specific niches where their unique pharmacology is useful: inducing medical coma for refractory brain swelling, managing seizures that don’t respond to first-line drugs, and providing ultra-short sedation for certain procedures. Outside these controlled settings, their clinical role has shrunk dramatically over the past few decades.